Cogentix Medical, Inc. (CGNT) Downgraded by Zacks Investment Research to “Hold”

Zacks Investment Research lowered shares of Cogentix Medical, Inc. (NASDAQ:CGNT) from a strong-buy rating to a hold rating in a report issued on Tuesday morning.

According to Zacks, “Cogentix Medical, Inc. is a medical device company which designs, develops, manufactures and markets proprietary technologies serving the urology market. The company’s primary product consists of Urgent(R) PC Neuromodulation System and EndoSheath System. It operates primarily in Orangeburg, New York, The Netherlands and the United Kingdom. Cogentix Medical, Inc., formerly known as Vision-Sciences Inc., is headquartered in Orangeburg, New York. “

Shares of Cogentix Medical (NASDAQ:CGNT) traded down 3.38% during midday trading on Tuesday, hitting $2.00. The company’s stock had a trading volume of 142,329 shares. Cogentix Medical has a 1-year low of $0.71 and a 1-year high of $2.99. The company’s market cap is $120.70 million. The company has a 50-day moving average price of $2.36 and a 200 day moving average price of $1.64.

TRADEMARK VIOLATION WARNING: “Cogentix Medical, Inc. (CGNT) Downgraded by Zacks Investment Research to “Hold”” was published by BBNS and is the propert of of BBNS. If you are accessing this piece on another domain, it was illegally copied and republished in violation of United States and international copyright law. The legal version of this piece can be viewed at https://baseballnewssource.com/markets/cogentix-medical-inc-cgnt-downgraded-by-zacks-investment-research-to-hold/345602.html.

In other news, Director Kenneth A. Samet acquired 25,000 shares of Cogentix Medical stock in a transaction that occurred on Friday, November 18th. The shares were acquired at an average price of $2.47 per share, for a total transaction of $61,750.00. Following the transaction, the director now directly owns 125,000 shares of the company’s stock, valued at approximately $308,750. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 35.50% of the company’s stock.

Cogentix Medical Company Profile

Cogentix Medical, Inc is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB).

5 Day Chart for NASDAQ:CGNT

Receive News & Ratings for Cogentix Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cogentix Medical Inc. and related companies with our FREE daily email newsletter.

 

Latest News

Toronto and Jose Bautista Agree to One-Year Deal
Toronto and Jose Bautista Agree to One-Year Deal
Orioles Talking Contract with Slugger Jose Bautista
Orioles Talking Contract with Slugger Jose Bautista
Criticism During World Series Humorous to Joe Maddon
Criticism During World Series Humorous to Joe Maddon
Los Angeles Dodgers Awaiting Decision by Twins on Brian Dozier
Los Angeles Dodgers Awaiting Decision by Twins on Brian Dozier
Manny Ramirez Returning to Play Baseball in Japan
Manny Ramirez Returning to Play Baseball in Japan
Rajai Davis Anxious to Start Second Stint With Oakland
Rajai Davis Anxious to Start Second Stint With Oakland


Leave a Reply

 
© 2006-2017 BBNS.